Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder October 4, 2023
Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations October 3, 2023
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor September 29, 2023
